Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
- PMID: 18364002
- PMCID: PMC3546504
- DOI: 10.1111/j.1600-065X.2008.00608.x
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Abstract
Patients with cancer have an impaired T-cell response that can decrease the potential therapeutic benefit of cancer vaccines and other forms of immunotherapy. L-arginine (L-Arg) is a conditionally essential amino acid that is fundamental for the function of T lymphocytes. Recent findings in tumor-bearing mice and cancer patients indicate that increased metabolism of L-Arg by myeloid derived suppressor cells (MDSCs) producing arginase I inhibits T-lymphocyte responses. Here we discuss some of the most recent concepts how MDSC expressing arginase I may regulate T-cell function in cancer and other chronic inflammatory diseases and suggest possible therapeutic interventions to overcome this inhibitory effect.
Figures
Similar articles
-
Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.Immunol Invest. 2012;41(6-7):614-34. doi: 10.3109/08820139.2012.680634. Immunol Invest. 2012. PMID: 23017138 Free PMC article. Review.
-
l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.Cancer Res. 2015 Jan 15;75(2):275-83. doi: 10.1158/0008-5472.CAN-14-1491. Epub 2014 Nov 18. Cancer Res. 2015. PMID: 25406192 Free PMC article.
-
Arginase-dependent suppression by CpG-ODN plus IFA-induced splenic myeloid CD11b(+)Gr1(+) cells.Immunol Cell Biol. 2012 Aug;90(7):710-21. doi: 10.1038/icb.2011.98. Epub 2011 Nov 15. Immunol Cell Biol. 2012. PMID: 22083526
-
PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.Immunol Invest. 2012;41(6-7):635-57. doi: 10.3109/08820139.2012.695417. Immunol Invest. 2012. PMID: 23017139 Review.
-
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.J Immunol. 2015 Dec 1;195(11):5237-50. doi: 10.4049/jimmunol.1500959. Epub 2015 Oct 21. J Immunol. 2015. PMID: 26491198 Free PMC article.
Cited by
-
Role of myeloid-derived suppressor cells in the formation of pre-metastatic niche.Front Oncol. 2022 Sep 27;12:975261. doi: 10.3389/fonc.2022.975261. eCollection 2022. Front Oncol. 2022. PMID: 36237333 Free PMC article. Review.
-
Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.J Virol. 2013 Feb;87(3):1477-90. doi: 10.1128/JVI.01759-12. Epub 2012 Nov 14. J Virol. 2013. PMID: 23152536 Free PMC article.
-
Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.Biol Blood Marrow Transplant. 2013 May;19(5):692-702. doi: 10.1016/j.bbmt.2013.01.008. Epub 2013 Jan 30. Biol Blood Marrow Transplant. 2013. PMID: 23376089 Free PMC article.
-
Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression.PLoS One. 2013;8(2):e55795. doi: 10.1371/journal.pone.0055795. Epub 2013 Feb 1. PLoS One. 2013. PMID: 23383347 Free PMC article.
-
Knockdown of serine/threonine-protein kinase 24 promotes tumorigenesis and myeloid-derived suppressor cell expansion in an orthotopic immunocompetent gastric cancer animal model.J Cancer. 2020 Jan 1;11(1):213-228. doi: 10.7150/jca.35821. eCollection 2020. J Cancer. 2020. PMID: 31892988 Free PMC article.
References
-
- Miescher S, Whiteside TL, Carrel S, von FV. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol. 1986;136:1899–1907. - PubMed
-
- Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Cancer Res. 1988;48:6992–6998. - PubMed
-
- Whiteside TL, Miescher S, Moretta L, von Fliedner V. Cloning and proliferating precursor frequencies of tumor-infiltrating lymphocytes from human solid tumors. Transplant Proc. 1988;20:342–343. - PubMed
-
- Hellstrom I, Sjogren HO, Warner G, Hellstrom KE. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971;7:226–237. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources